Qube Research & Technologies (QRT)
EBS icon

Qube Research & Technologies (QRT)’s Emergent Biosolutions EBS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-167,057
Closed -$1.47M – 3764
2025
Q3 		$1.47M Sell
167,057
-179,871
-52% -$1.4M ﹤0.01% 2367
2025
Q2 		$2.21M Sell
346,928
-740,415
-68% -$4.24M ﹤0.01% 2165
2025
Q1 		$5.28M Buy
1,087,343
+271,550
+33% +$2.25M 0.01% 1496
2024
Q4 		$7.8M Buy
815,793
+477,845
+141% +$4.38M 0.01% 1242
2024
Q3 		$2.82M Buy
337,948
+63,794
+23% +$580K ﹤0.01% 1621
2024
Q2 		$1.87M Buy
+274,154
New +$1.18M ﹤0.01% 1657
2024
Q1 		– Sell
-621,177
Closed -$1.49M – 4561
2023
Q4 		$1.49M Buy
+621,177
New +$1.46M ﹤0.01% 1690
2023
Q3 		– Sell
-36,158
Closed -$266K – 4136
2023
Q2 		$266K Buy
+36,158
New +$335K ﹤0.01% 1692
2023
Q1 		– Sell
-135,889
Closed -$1.6M – 2656
2022
Q4 		$1.6M Buy
135,889
+91,261
+204% +$1.41M 0.01% 1031
2022
Q3 		$937K Buy
44,628
+22,089
+98% +$615K 0.01% 1230
2022
Q2 		$700K Buy
22,539
+474
+2% +$16.2K 0.01% 1272
2022
Q1 		$906K Buy
+22,065
New +$973K 0.01% 1222
2021
Q4 		– Sell
-14,355
Closed -$719K – 2624
2021
Q3 		$719K Buy
14,355
+4,689
+49% +$284K 0.01% 1037
2021
Q2 		$609K Buy
+9,666
New +$621K 0.01% 1178
2020
Q4 		– Sell
-18,530
Closed -$1.92M – 1898
2020
Q3 		$1.92M Buy
+18,530
New +$2M 0.03% 647

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EBS Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 167,057 shares — an estimated $1.47M sold.

Qube Research & Technologies (QRT) first reported a position in EBS in Q3 2020 and held it in 15 quarters. The position peaked at $7.8M in Q4 2024. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 167,057 Emergent Biosolutions shares in Q4 2025, an estimated $1.47M.
  • Qube Research & Technologies (QRT) first reported a position in Emergent Biosolutions in Q3 2020 and held it in 15 quarters.
  • Qube Research & Technologies (QRT)'s Emergent Biosolutions position peaked at $7.8M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.